Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis

Area of Science:

• Nephrology
• Immunopathology

Background:

• Antiglomerular basement membrane (GBM) disease typically presents with linear IgG deposition along the GBM.
• Concurrent glomerular immune complex deposition is increasingly recognized and may play a role in anti-GBM disease pathogenesis.

Observation:

• Glomerular immune complexes were identified in 10 of 47 patients with biopsy-proven anti-GBM disease.
• These patients had co-existing glomerulonephritis or immune deposits in the mesangium without a defined glomerulonephritis.
• No significant differences in clinical or pathological features and renal outcomes were observed between patients with and without immune complex deposition.

Findings:

• The presence of glomerular immune complexes in anti-GBM disease does not appear to confer a benign prognosis.
• Immune complex deposition may be involved in the initiation of anti-GBM disease.

Implications:

• Early plasma exchange and aggressive immunosuppressive therapy are crucial for managing anti-GBM disease, even with concurrent immune complex deposition.
• Further research is warranted to elucidate the precise role of immune complexes in anti-GBM disease initiation and progression.